ImmuONE Secures £600K to Enhance Ethical Testing Methods
Pioneering Change in Biotech: ImmuONE Secures £600K to Transform Animal Testing
In a groundbreaking move, ImmuONE, a dynamic biotech startup based in Stevenage, UK, has successfully raised £600K in funding to revolutionize the realm of animal testing. This significant investment, supported by esteemed backers such as the Midlands Engine Investment Fund, Mercia Ventures, and Pioneer Group, marks a critical step forward in offering sustainable alternatives to traditional testing methods. With the backing of these empowered investors, ImmuONE is set to redefine how industries approach testing in an ethical and efficient manner.
The funds will be strategically utilized to enhance ImmuONE’s capabilities and expand into new sectors, including agrichemicals and automotive.
Additionally, the company plans to bolster its team by bringing on two new experts in the field. Founded in 2019 by visionary leaders Dr. Abigail Martin and Professor Victoria Hutter from the University of Hertfordshire, ImmuONE is at the forefront of biotech innovation, offering a sophisticated 3D human lung model that significantly reduces the reliance on animal testing. This model not only supports respiratory safety assessments but also incorporates advanced immunology tests that evaluate the long-term effects of various substances on lung health.
As ImmuONE continues to grow, the company has also attracted new clients within the chemicals sector, effectively expanding its existing clientele that includes notable consumer products and pharmaceutical companies. This diversification highlights the startup's potential for attracting further investment and positioning itself as a leader in ethical biotech solutions. As more investors recognize the critical importance of sustainable practices, ImmuONE stands poised not just to make an impact in the biotech industry but to lead the charge towards an animal-friendly future in scientific research.
Key Terms Explained
- Biotech startup
- A business startup in the field of biotechnology, which applies biological sciences, biochemistry etc, to deliver away technological applications that improve the health and lives of people.
- £600K in funding
- An amount of money, in this case 600,000 pounds, that has been raised by a company to fund its operations.
- Investors
- Individuals or corporations that provide funds or resources to a business with the expectation of eventual monetary return.
Frequently Asked Questions
- How much funding has biotech startup ImmuONE successfully raised?-ImmuONE has successfully raised £600K in funding.
- Who are some of the investors that have supported ImmuONE's animal testing revolution?+
- What will the funds raised by ImmuONE be used for?+
- What kind of testing model does ImmuONE offer?+
- What sectors has ImmuONE managed to attract new clients from?+
They've invested in ImmuONE
Get to know these Biotech investors
Click here for a full list of 7,526+ startup investors in the UK